TSC1 and neoplasm: Alterations in cell cycle regulatory genes were also detected in the tumor DNA of patients enrolled in the phase Ib BISCAY trial, in which 15% of patients with UC carried an amplification in RICTOR or a deleterious alteration in TSC1/TSC2 [37].